TCL Archive Despite NCI director’s enthusiasm, “We have a long way to go before we beat cancer,” the former NIH director says. May 20, 2005Vol.31 No.20
TCL Archive An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists. May 13, 2005Vol.31 No.19
TCL Archive University of Pittsburgh honors breast cancer surgeon and clinical trialist Bernard Fisher with lecture and portrait. May 13, 2005Vol.31 No.19
TCL Archive NIH oncology peer reviewers are protesting the outcome of a recent meeting in which their own grant applications fared so poorly that the reviewers said they were penalized for their service. May 06, 2005Vol.31 No.18
TCL Archive Also in this 8-page issue: FISH assay predicts survival on Iressa, Univ. of Colorado Cancer Center study finds. May 06, 2005Vol.31 No.18
TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 06, 2005Vol.31 No.18
TCL Archive Cancer research poised for a “platinum age” as a “golden age” ends, NCI director tells AACR annual meeting. April 29, 2005Vol.31 No.17
TCL Archive NCI Closes Iressa Trial For NSCLC When Data Indicate No Survival Benefit April 29, 2005Vol.28 No.4
TCL Archive Also FDA clarifies data requirements for phase I IND applications. April 29, 2005Vol.31 No.17
